首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

1830969

電療系統市場

Electrotherapy Systems Market

出版日期: 2025年09月24日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

2024 年電療系統市場價值約 49.9 億美元，預計到 2031 年將成長至約 94.2 億美元。預計 2025 年至 2031 年期間市場複合年成長率為 8.1%。市場洞察與分析師觀點：本報告概述了基於電療系統市場當前趨勢的成長機會及其在預測期內的預期影響。

電療系統是一種醫療設備，旨在透過向患者組織輸送電流來增強其肌肉功能。電療可有效緩解急性創傷後和術後疼痛，促進傷口癒合，緩解肌肉痙攣，預防和緩解廢用性萎縮，輔助肌肉康復，維持和增強活動範圍，以及緩解急性創傷後和術後疼痛。通常，電療裝置由一個電池供電的設備連接到粘附在皮膚上的黏性電極片組成。運動傷害發生率的上升以及製造商的策略性舉措等因素正在推動電療系統市場的成長。

市場促進因素：癌症、心血管疾病、神經血管疾病和肌肉骨骼疾病等慢性疾病的日益普及預計將推動疼痛管理設備市場的成長。這些疾病會削弱免疫力並引起慢性疼痛，嚴重影響個人健康。慢性病最常見於成年人和老年族群。例如，美國疾病管制與預防中心的資料顯示，2019 年至 2021 年間，美國成年人慢性疼痛的盛行率為 20.5% 至 21.8%，其中高強度慢性疼痛的盛行率為 6.9% 至 7.8%。 2021 年，約有 5,160 萬美國成年人患有慢性疼痛，其中 1,710 萬人面臨高強度慢性疼痛。

此外，慢性疼痛在運動員、運動愛好者和曾經受傷的人群中普遍存在。慢性疼痛會增加人們在日常活動中對他人的依賴，因此疼痛管理對於維持正常生活至關重要。電療系統能夠提供持久的緩解，並有助於改善健康狀況，從而推動電療系統市場的成長。

根據2022年7月發布的《脊髓損傷事實與統計》報告，每年約有17,700名美國人遭受脊髓損傷，其中約78%為男性，平均年齡為43歲。美國國家安全委員會的估計表明，2021年美國有近320萬人因與運動和娛樂設備相關的傷害到急診室就診。因此，高脊髓損傷率支持了電療系統市場的成長。

《聯邦食品、藥品和化妝品法案》將電肌肉刺激器 (EMS) 歸類為設備。 FDA 根據立法和該機構的指南監管美國所有電肌肉刺激器的銷售。因此，除非公司遵守所有相關的 FDA 上市前監管要求，否則它們不能合法銷售其刺激器。 FDA 評估的大多數電肌肉刺激器旨在在醫生的監督下用於物理治療和復健。如果公司希望將 EMS 設備直接銷售給消費者，則必須向 FDA 證明其 EMS 設備可以安全有效地用於該環境。銷售 EMS 設備的公司必須遵守適用的 FDA 上市前監管標準，然後才能合法銷售其產品。因此，對電療產品的嚴格監管要求可能會阻礙電療系統市場的成長。

策略洞察報告細分和範圍：透過檢查以下細分市場來分析電療系統市場：產品、應用和最終用戶。

分段分析：電療系統市場按產品細分為經皮神經電刺激 (PENS)、經皮神經電刺激 (TENS)、脊髓刺激 (SCS)、微電流療法、干擾電流療法 (IC)、電針 (EA)、脈衝短波透熱療法 (PSWD)、經皮脊髓電鎮痛 (TSE) 等。脊髓刺激細分市場在 2022 年佔據最大市場佔有率，預計在 2022 年至 2030 年期間將達到最高複合年成長率。脊髓刺激已在醫療機構中使用多年。頸椎和腰椎神經根炎、背部手術失敗症候群、複雜性區域疼痛症候群和神經病變等疾病可從此療法中受益。脊髓刺激是一種有效、安全且經濟高效的慢性疼痛治療方法。較新的脊髓刺激技術正在開發中，以解決更廣泛的臨床適應症，包括內臟疼痛和缺血性疼痛，並有可能提高療效。

根據應用，市場分為神經肌肉功能障礙、疼痛管理、急性和慢性水腫、運動傷害治療、離子電滲透療法、失禁等。疼痛管理部分在 2022 年佔據了電療系統市場的最大佔有率，預計在 2022 年至 2030 年期間將呈現最高的複合年成長率。這一領域的成長是由創傷和運動傷害日益普遍所驅動的。根據世界衛生組織 2022 年 3 月發布的資料，近 3,000 萬名兒童和青少年參與有組織的運動，導致每年報告的傷害超過 350 萬起。此外，據估計，2021 年美國有 57 萬人經歷過創傷性疼痛。背痛和頸痛的增加也導致電療治療慢性疼痛的需求不斷增加。

按最終用戶分類，電療系統市場分為醫院、診所、長期護理機構、復健中心和其他。 2022年，醫院佔據了電療系統市場的最大佔有率。

區域分析：電療系統市場報告涵蓋北美（美國、加拿大和墨西哥）、歐洲（西班牙、英國、德國、法國、義大利和歐洲其他地區）、亞太地區（韓國、中國、印度、日本、澳洲和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國和中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和其他地區）。就收入而言，北美在 2022 年引領了電療系統市場。人口老化是該地區對電療需求增加的重要因素。根據世界衛生組織 2022 年 12 月發布的資料，估計到 2053 年，北美將有 7,300 萬人年齡在 65 歲或以上。同一來源還表明，17% 的 65 歲以上的美國人口患有背痛和脊椎損傷。

電療系統市場報告範圍、競爭格局和主要公司：本電療系統市場報告重點關注行業主要參與者，包括BTL、DJO LLC、歐姆龍醫療保健公司、雅培、波士頓科學公司、美敦力、Nevro Corp、Phoenix Healthcare、Eme srl和Pure Care。這些公司致力於開發新技術、改進現有產品並擴大市場佔有率，以滿足日益成長的全球消費者需求。電療系統市場預測可以幫助利害關係人規劃其成長策略。

2022年1月，全球領先的醫療科技公司美敦力公司（Medtronic plc）獲得美國食品藥物管理局（FDA）批准其Intellis（可充電）和Vanta（免充電）神經刺激器用於治療糖尿病周邊神經病變（DPN）相關的慢性疼痛。這項新適應症使DPN患者能夠使用美敦力領先的SCS產品組合，該組合包括多種個人化治療編程選項、不受限制的MRI訪問、卓越的電池化學成分和性能，以及美敦力TYRX Neuro可吸收抗菌包膜。 2021年3月，FDA批准了美敦力公司針對其具有差異靶點連接複用（DTM）編程功能的Intellis平台提交的修訂商業標籤申請。新的標籤包含了一項多中心隨機對照試驗的研究結果，強調了DTM SCS相比傳統SCS在緩解背痛方面更佳的療效。 2020年9月，波士頓科學公司（Boston Scientific）在歐洲推出了WaveWriter Alpha系列SCS系統。該產品組合包含四款支援藍牙的MRI條件式植入式脈衝產生器 (IPG)，可根據患者需求提供更個人化的客製化服務。這些產品提供可充電和不可充電兩種選擇，並支援針對多個疼痛區域的波形。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 11 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 12 章：競爭格局

關鍵參與者的熱圖分析
公司定位與集中度

第 13 章：電療系統市場 - 主要公司簡介

BTL Industries LLC
DJO, LLC
Omron Healthcare, Inc.
Medtronic plc
Boston Scientific Corporation
Nevro Corporation
Abbott
EME srl
Phoenix Healthcare
Pure Care

第 14 章：附錄

簡介目錄

Product Code: TIPHE100001378

The electrotherapy systems market was valued at approximately US$ 4.99 billion in 2024 and is projected to grow to around US$ 9.42 billion by 2031. The market is anticipated to experience a CAGR of 8.1% from 2025 to 2031.Market Insights and Analyst Perspective:This report outlines growth opportunities based on current trends in the electrotherapy systems market and their expected effects during the forecast period.

An electrotherapy system is a medical device designed to enhance a patient's muscle function by delivering electric currents through their tissues. Electrotherapy is effective in managing acute post-traumatic and post-surgical pain, promoting wound healing, relaxing muscle spasms, preventing and alleviating disuse atrophy, assisting in muscle rehabilitation, maintaining and enhancing range of motion, and alleviating acute post-traumatic and post-surgical pain. Typically, electrotherapy units consist of a battery-operated device connected to adhesive electrode pads that adhere to the skin. Factors such as the rising incidence of sports injuries and strategic initiatives by manufacturers are driving the growth of the electrotherapy systems market.

Market Drivers:The increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, neurovascular diseases, and musculoskeletal disorders, is expected to fuel the growth of the pain management devices market. These conditions significantly impact an individual's health by weakening immunity and causing chronic pain. Chronic diseases are most frequently observed in adults and the elderly population. For example, data from the Centers for Disease Control and Prevention indicates that between 2019 and 2021, the prevalence of chronic pain among US adults ranged from 20.5% to 21.8%, with high-impact chronic pain affecting 6.9% to 7.8%. In 2021, approximately 51.6 million US adults experienced chronic pain, and 17.1 million faced high-impact chronic pain.

Moreover, chronic pain is often prevalent among athletes, sports enthusiasts, and individuals with previous injuries. The occurrence of chronic pain increases a person's reliance on others for daily activities, making pain management crucial for maintaining a normal routine. Electrotherapy systems offer prolonged relief and contribute to improved health, thus driving the growth of the electrotherapy systems market.

According to the report "Spinal Cord Injury Facts and Stats" published in July 2022, approximately 17,700 Americans sustain a spinal cord injury each year, with around 78% being men and an average age of 43. Estimates from the National Safety Council indicate that nearly 3.2 million individuals in the US sought treatment in emergency departments for injuries related to sports and recreational equipment in 2021. Consequently, the high rate of spinal cord injuries supports the growth of the electrotherapy systems market.

The Federal Food, Drug, and Cosmetic Act categorizes electrical muscle stimulators (EMS) as devices. The FDA regulates the sale of all electrical muscle stimulators in the US according to the legislation and the agency's guidelines. Therefore, companies cannot legally sell their stimulators unless they comply with all relevant FDA premarket regulatory requirements. Most electrical muscle stimulators evaluated by the FDA are intended for use in physical therapy and rehabilitation under a physician's supervision. Companies must demonstrate to the FDA that their EMS devices can be safely and effectively used in that context if they wish to sell them directly to consumers. Companies marketing EMS devices must adhere to the applicable FDA premarket regulatory standards before they can legally sell their products. Thus, stringent regulatory requirements for electrotherapy products can hinder the growth of the electrotherapy systems market.

Strategic Insights

Report Segmentation and Scope:The analysis of the electrotherapy systems market has been conducted by examining the following segments: product, application, and end user.

Segmental Analysis:The electrotherapy systems market is segmented by product into percutaneous electrical nerve stimulation (PENS), transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation (SCS), micro-current therapy, interferential current therapy (IC), electro-acupuncture (EA), pulsed short wave diathermy (PSWD), transcutaneous spinal electroanalgesia (TSE), and others. The spinal cord stimulation segment held the largest market share in 2022 and is expected to register the highest CAGR from 2022 to 2030. Spinal cord stimulation has been utilized in medical facilities for many years. Conditions such as cervical and lumbar radiculitis, failed back surgery syndrome, complex regional pain syndrome, and neuropathy can benefit from this therapy. Spinal cord stimulation is an effective, safe, and cost-efficient method for managing chronic pain. Newer spinal cord stimulation technologies are being developed to address a broader range of clinical indications, including visceral and ischemic pain, with the potential for enhanced efficacy.

By application, the market is divided into neuromuscular dysfunction, pain management, acute and chronic edema, sports injury treatment, iontophoresis, urinary and fecal incontinence, and others. The pain management segment accounted for the largest share of the electrotherapy systems market in 2022 and is projected to exhibit the highest CAGR from 2022 to 2030. The growth of this segment is driven by the increasing prevalence of trauma and sports injuries. According to data from the World Health Organization released in March 2022, nearly 30 million children and teenagers participate in organized sports, resulting in over 3.5 million reported injuries annually. Additionally, it was estimated that 570,000 individuals experienced traumatic pain in the US in 2021. An increase in back pain and neck pain also contributes to the rising demand for electrotherapy to manage chronic pain.

By end user, the electrotherapy systems market is categorized into hospitals, clinics, long-term care facilities, rehabilitation centers, and others. In 2022, the hospitals segment represented the largest share of the electrotherapy systems market.

Regional Analysis:The electrotherapy systems market report encompasses North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, UAE, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In terms of revenue, North America led the electrotherapy systems market in 2022. The aging population is a significant factor contributing to the increased demand for electrotherapy in the region. According to WHO data released in December 2022, it is estimated that by 2053, 73 million individuals in North America will be aged 65 or older. The same source indicates that 17% of the US population over 65 years old experiences back pain and spinal injuries.

Electrotherapy Systems Market Report Scope

Competitive Landscape and Key Companies:The electrotherapy systems market report focuses on key players in the industry, including BTL, DJO LLC, Omron Healthcare Inc, Abbott, Boston Scientific Corporation, Medtronic, Nevro Corp, Phoenix Healthcare, Eme srl, and Pure Care. These companies are dedicated to developing new technologies, enhancing existing products, and expanding their market presence to meet the growing global consumer demand. The electrotherapy systems market forecast can assist stakeholders in planning their growth strategies.

In January 2022, Medtronic plc, a global leader in healthcare technology, received FDA approval for its Intellis (rechargeable) and Vanta (recharge-free) neurostimulators for treating chronic pain associated with diabetic peripheral neuropathy (DPN). This new indication provides DPN patients access to Medtronic's leading SCS portfolio, which includes multiple programming options for personalized therapy, unrestricted MRI access, and superior battery chemistry and performance, along with the Medtronic TYRX Neuro Absorbable Antibacterial Envelope.

In March 2021, the FDA approved Medtronic plc's application for revised commercial labeling for its Intellis platform with Differential Target Multiplexed (DTM) programming. The new labeling included study outcomes from a multicenter randomized control trial, highlighting superior back pain relief provided by DTM SCS compared to conventional SCS.

In September 2020, Boston Scientific launched the WaveWriter Alpha portfolio of SCS systems in Europe. This portfolio includes four MRI conditional, Bluetooth-enabled implantable pulse generators (IPGs) that offer greater personalization based on patient needs. The products feature both rechargeable and non-rechargeable options, as well as access to waveforms that address multiple pain areas.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Electrotherapy System Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Electrotherapy System Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Electrotherapy System Market - Global Market Analysis

6.1 Electrotherapy System - Global Market Overview
6.2 Electrotherapy System - Global Market and Forecast to 2030

7. Electrotherapy System Market - Revenue Analysis (USD Million) - By Product, 2020-2030

7.1 Overview
7.2 Percutaneous Electrical Nerve Stimulation (PENS)
7.3 Spinal Cord Stimulation (SCS)
7.4 Transcutaneous Electrical Nerve Stimulation (TENS)
7.5 Micro-Current Therapy
7.6 Interferential Current Therapy (IC)
7.7 Electro-Acupuncture (EA)
7.8 Pulsed Short Wave Diathermy (PSWD)
7.9 Transcutaneous Spinal Electroanalgesia (TSE)
7.10 Others

8. Electrotherapy System Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Neuromuscular Dysfunction
8.3 Pain Management
8.4 Acute and Chronic Edema
8.5 Sports Injury Treatment
8.6 Tissue Repair
8.7 Iontophoresis
8.8 Urine and Fecal Incontinence
8.9 Others

9. Electrotherapy System Market - Revenue Analysis (USD Million) - By End User, 2020-2030

9.1 Overview
9.2 Hospitals
9.3 Clinics
9.4 Rehabilitation Centers
9.5 Long Term Care Centers
9.6 Others

10. Electrotherapy System Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Electrotherapy System Market Overview
- 10.1.2 North America Electrotherapy System Market Revenue and Forecasts to 2030
- 10.1.3 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By Product
- 10.1.4 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By Application
- 10.1.5 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By End User
- 10.1.6 North America Electrotherapy System Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Electrotherapy System Market
    - 10.1.6.1.1 United States Electrotherapy System Market, by Product
    - 10.1.6.1.2 United States Electrotherapy System Market, by Application
    - 10.1.6.1.3 United States Electrotherapy System Market, by End User
  - 10.1.6.2 Canada Electrotherapy System Market
    - 10.1.6.2.1 Canada Electrotherapy System Market, by Product
    - 10.1.6.2.2 Canada Electrotherapy System Market, by Application
    - 10.1.6.2.3 Canada Electrotherapy System Market, by End User
  - 10.1.6.3 Mexico Electrotherapy System Market
    - 10.1.6.3.1 Mexico Electrotherapy System Market, by Product
    - 10.1.6.3.2 Mexico Electrotherapy System Market, by Application
    - 10.1.6.3.3 Mexico Electrotherapy System Market, by End User
10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Electrotherapy System Market - Key Company Profiles

13.1 BTL Industries LLC
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 DJO, LLC
13.3 Omron Healthcare, Inc.
13.4 Medtronic plc
13.5 Boston Scientific Corporation
13.6 Nevro Corporation
13.7 Abbott
13.8 EME srl
13.9 Phoenix Healthcare
13.10 Pure Care